Cargando…
The use of assisted reproductive technology before male factor infertility evaluation
BACKGROUND: Some centers offer assisted reproductive technologies (ARTs) [intra-uterine insemination (IUI) and in-vitro fertilization (IVF)], to treat certain couples with male factor infertility without having the men assessed by male infertility specialists. We sought to compare characteristics of...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127534/ https://www.ncbi.nlm.nih.gov/pubmed/30211059 http://dx.doi.org/10.21037/tau.2018.06.08 |
_version_ | 1783353492502478848 |
---|---|
author | Nayan, Madhur Punjani, Nahid Grober, Ethan Lo, Kirk Jarvi, Keith |
author_facet | Nayan, Madhur Punjani, Nahid Grober, Ethan Lo, Kirk Jarvi, Keith |
author_sort | Nayan, Madhur |
collection | PubMed |
description | BACKGROUND: Some centers offer assisted reproductive technologies (ARTs) [intra-uterine insemination (IUI) and in-vitro fertilization (IVF)], to treat certain couples with male factor infertility without having the men assessed by male infertility specialists. We sought to compare characteristics of couples having or not having prior ART use. METHODS: We used our prospectively collected database to identify men undergoing an initial evaluation for male infertility between 1995–2017. We obtained data on patient demographics, use of IUI and IVF, and semen analysis parameters. We used multivariable logistic regression to identify characteristics associated with prior use of ART. RESULTS: One thousand and five hundred forty-five out of 8,962 (17.2%) men reported use of ARTs prior to evaluation. Of these, 258 tried both IUI and IVF. More than one attempt was reported in 470 (37.2%) and 154 (28.2%) of men with prior IUI and IVF, respectively. Younger male age [adjusted odds ratio (aOR) 0.97/year; 95% confidence interval (CI), 0.95 to 0.99], older female partner age (aOR 1.07/year; 95% CI, 1.04 to 1.10), and year of visit (aOR 1.05/year; 95% CI, 1.01 to 1.09) were significantly associated with prior IUI. Older female partner age (aOR 1.07/year; 95% CI, 1.02 to 1.12) was significantly associated with prior IVF, but not male age or year of visit. Semen analysis parameters were not associated with prior ART. CONCLUSIONS: The prior use of ART is common among men presenting for an initial evaluation at a male infertility specialty clinic. Older female partner age was associated with use of reproductive technologies prior to evaluation, however, semen analysis parameters were not. |
format | Online Article Text |
id | pubmed-6127534 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-61275342018-09-12 The use of assisted reproductive technology before male factor infertility evaluation Nayan, Madhur Punjani, Nahid Grober, Ethan Lo, Kirk Jarvi, Keith Transl Androl Urol Original Article BACKGROUND: Some centers offer assisted reproductive technologies (ARTs) [intra-uterine insemination (IUI) and in-vitro fertilization (IVF)], to treat certain couples with male factor infertility without having the men assessed by male infertility specialists. We sought to compare characteristics of couples having or not having prior ART use. METHODS: We used our prospectively collected database to identify men undergoing an initial evaluation for male infertility between 1995–2017. We obtained data on patient demographics, use of IUI and IVF, and semen analysis parameters. We used multivariable logistic regression to identify characteristics associated with prior use of ART. RESULTS: One thousand and five hundred forty-five out of 8,962 (17.2%) men reported use of ARTs prior to evaluation. Of these, 258 tried both IUI and IVF. More than one attempt was reported in 470 (37.2%) and 154 (28.2%) of men with prior IUI and IVF, respectively. Younger male age [adjusted odds ratio (aOR) 0.97/year; 95% confidence interval (CI), 0.95 to 0.99], older female partner age (aOR 1.07/year; 95% CI, 1.04 to 1.10), and year of visit (aOR 1.05/year; 95% CI, 1.01 to 1.09) were significantly associated with prior IUI. Older female partner age (aOR 1.07/year; 95% CI, 1.02 to 1.12) was significantly associated with prior IVF, but not male age or year of visit. Semen analysis parameters were not associated with prior ART. CONCLUSIONS: The prior use of ART is common among men presenting for an initial evaluation at a male infertility specialty clinic. Older female partner age was associated with use of reproductive technologies prior to evaluation, however, semen analysis parameters were not. AME Publishing Company 2018-08 /pmc/articles/PMC6127534/ /pubmed/30211059 http://dx.doi.org/10.21037/tau.2018.06.08 Text en 2018 Translational Andrology and Urology. All rights reserved. |
spellingShingle | Original Article Nayan, Madhur Punjani, Nahid Grober, Ethan Lo, Kirk Jarvi, Keith The use of assisted reproductive technology before male factor infertility evaluation |
title | The use of assisted reproductive technology before male factor infertility evaluation |
title_full | The use of assisted reproductive technology before male factor infertility evaluation |
title_fullStr | The use of assisted reproductive technology before male factor infertility evaluation |
title_full_unstemmed | The use of assisted reproductive technology before male factor infertility evaluation |
title_short | The use of assisted reproductive technology before male factor infertility evaluation |
title_sort | use of assisted reproductive technology before male factor infertility evaluation |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127534/ https://www.ncbi.nlm.nih.gov/pubmed/30211059 http://dx.doi.org/10.21037/tau.2018.06.08 |
work_keys_str_mv | AT nayanmadhur theuseofassistedreproductivetechnologybeforemalefactorinfertilityevaluation AT punjaninahid theuseofassistedreproductivetechnologybeforemalefactorinfertilityevaluation AT groberethan theuseofassistedreproductivetechnologybeforemalefactorinfertilityevaluation AT lokirk theuseofassistedreproductivetechnologybeforemalefactorinfertilityevaluation AT jarvikeith theuseofassistedreproductivetechnologybeforemalefactorinfertilityevaluation AT nayanmadhur useofassistedreproductivetechnologybeforemalefactorinfertilityevaluation AT punjaninahid useofassistedreproductivetechnologybeforemalefactorinfertilityevaluation AT groberethan useofassistedreproductivetechnologybeforemalefactorinfertilityevaluation AT lokirk useofassistedreproductivetechnologybeforemalefactorinfertilityevaluation AT jarvikeith useofassistedreproductivetechnologybeforemalefactorinfertilityevaluation |